Nanoscale Medical Devices Can Have Huge Effects

A bioengineer sculpts medical devices at the nanoscale

By Marissa Fessenden

Join Our Community of Science Lovers!

PROFILE

NAME
Tejal Desai

TITLE
Professor of bioengineering and therapeutic sciences

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

LOCATION
University of California, San Francisco

All creatures struggle with a common problem: they must let in nutrients and vent wastes while also keeping pathogens and poisons out. At a cellular level, humans and other vertebrates safeguard their bodies using “tight junctions,” watertight bonds between adjacent cells. Tight junctions are in almost all our tissues and even help waterproof our skin. But they also make it very difficult for drugs to get into the body’s tissues from the outside world.

Nanoscale and microscale drug-delivery devices as small as a few atoms or as large as the width of a human hair can interact with tight junctions and other cellular features to more effectively administer drugs to patients. For example, we have developed a tiny film with nanoscale wire-shaped features that cells like to grab onto. The film activates certain chemical pathways in the cells that alter cell membrane structure and prop open the tight junctions. That allows doctors to use reduced, less dangerous doses of highly toxic anticancer drugs or to get more of a drug to a certain part of the body. For example, particles to treat diabetes could stick to the intestinal wall and release insulin over time rather than quickly flushing out of the body.

One device we are developing is for age-related macular degeneration, which causes blindness if left untreated. Right now patients go to the doctor and have a needle poked into their eye once a month to deliver the drug. Our nanoscale device can be delivered in a single injection, and it lasts from six months to a year. It would sit in the back of the eye and deliver the drug over time through microscopic pores, then dissolve away once it is emptied.

In the future, we will see particles with nanoscale parts that can not only target specific sites but also improve a drug’s absorption within the body by prying open tight junction barriers.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American